Sciele Pharma Inc. v. Lupin Ltd.

NOTE: ThiS order is nonprecedential United States Court of AppeaIs for the FederaI Circuit SCIELE PHARMA INC. (NOW KNOWN AS SHIONOGI PHARMA INC.), AND'RX CORPORATION, ANDRX PI-IARMACEUTICALS INC. (DOING BUSINESS AS WATSON LABORATORIES INC. - FLORIDA), ANDRX PHARMACEUTICALS L.L.C., ANDRX LABORATORIES (NJ) INC., ANDRX EU LTD., AND ANDRX LABS L.L.C., ~ Plaintiffs-Appellees, _ V. LUPIN LTD. AND LUPIN PHARMACEUTICALS INC., Defen,dants-Appellants, AND MYLAN INC. AND MYLAN PHARMACEUTICALS INC., Defen,dan,ts. 2012-1118 Appea1 from the United States District Court for the District of Delaware in consolidated case no. 09-CV-0037, Judge R0bert B. Kug1er. sC1ELE PHARMA v. LUPIN mo 2 0N MOTION Before LINN, Circuit Ju,dge. 0 R D E R Lupin Ltd. et al. submit a motion for a stay, pending appeal, of the preliminary injunction entered by the United States District Court for the District of Delaware on December 6, 2011. Lupin also moves to expedite the appeal Lupin states that the appellees oppose. Upon consideration thereof, IT ls ORDERED THAT: (1) The appellees are directed to respond to theme- tion for a stay no later than 5:00pm on January 9, 2012. Lupin’s reply is due no later than January 13, 20l2. (2) The motion for expedited briefing on the merits is granted to the extent that Lupin’s opening brief is due within seven days from the date of filing of this order, the appellees’ response brief is due within twenty-one days from the date of service of Lupin’s opening brief, and Lupin’s reply brief is due within seven days from the date of service of the appellees response brief. Expedited service should be used for the briefs. nor 2 9 2011 ”/`33§§Z‘§F§l,,;T Date J an Horbaly Clerk cc: Douglass C. Hochstetler, Esq. F8LEDp . . EALSFOR DaV1d B. Bassett, Esq. u's1Eg?:`§Bg;'»:AFg\Rgun Mary B. Matterer, Esq. nw 2 9 2011 s19 lAN HORBALY CLERi(